This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Gaudium IVF & Women Health IPO
Business initial public offering

Gaudium IVF & Women Health IPO

Analysis based on 6 articles · First reported Feb 20, 2026 · Last updated Feb 24, 2026

Sentiment
20
Attention
4
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The Gaudium IVF IPO is expected to have a moderately positive debut, with its shares trading at an 11% premium in the grey market. This event provides investors with exposure to India's growing fertility services segment, potentially boosting investor confidence in the healthcare sector.

Healthcare Financial Services
Event Summary

Gaudium IVF has launched its Rs 165 crore initial public offering (IPO), which opened for subscription on February 20 and will close on February 24. The IPO comprises a fresh issue of Rs 90 crore and an offer for sale of Rs 75 crore, with shares priced between Rs 75 and Rs 79. The company plans to use Rs 50 crore from the fresh issue to establish new IVF centres and Rs 20 crore to repay outstanding loans. Early bidding saw strong interest from retail investors, with the overall subscription reaching 88% on Day 1 and 1.19x by Day 2. The grey market premium (GMP) indicates an estimated listing price of around Rs 87.5 per share, suggesting a moderately positive debut. Brokerage firms like Swastika Investmart, Kunvarji Wealth Solutions, JM Financial, and BP Wealth have largely recommended 'Subscribe' to the issue, citing Gaudium IVF's position as India's first pure-play listed fertility services company, improving profitability, and scalable hub-and-spoke model, while also noting risks such as premium valuation and a tax dispute.

Entities Involved
priv
Gaudium IVF
Gaudium IVF is undergoing an initial public offering to raise capital for expansion and debt repayment, aiming for a positive market debut.
Importance 100.0 Sentiment 20.0
priv
Kunvarji Wealth Solutions
Kunvarji Wealth Solutions has recommended 'Subscribe' to the Gaudium IVF IPO, citing the company's expanding presence and improving financial profile.
Importance 30.0 Sentiment 10.0
priv
BP Wealth
BP Wealth assigned a 'Subscribe' rating to the Gaudium IVF IPO, based on its valuation and growth strategy.
Importance 30.0 Sentiment 10.0
priv
Swastika Investmart
Swastika Investmart has assigned a 'Subscribe' rating to the Gaudium IVF IPO, highlighting its position as India's first pure-play listed fertility services company.
Importance 30.0 Sentiment 10.0
per
Manika Khanna
Manika Khanna is the founder of Gaudium IVF and is offering shares in the IPO.
Importance 20.0 Sentiment 10.0
priv
Sarthi Capital Advisors
Sarthi Capital Advisors is the sole book running lead manager for the Gaudium IVF IPO.
Importance 10.0 Sentiment 0.0
priv
Bigshare Services Private Limited
Bigshare Services Private Limited is the registrar of the Gaudium IVF IPO.
Importance 10.0 Sentiment 0.0
priv
Indira IVF Hospital
Indira IVF Hospital confidentially filed draft papers for an IPO, indicating potential future competition in the fertility care sector.
Importance 5.0 Sentiment 0.0
stock
JM Financial
Importance 0.0 Sentiment 0.0
exch
BSE
Importance 0.0 Sentiment 0.0
exch
National Stock Exchange of India
Importance 0.0 Sentiment 0.0
Relationships
JM Financial related ↔ BSE
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.